November 3, 2017
October 27, 2017
Genetic Engineering and Biotechnology News ‘Of Biomarkers and CDxes’,
October 12, 2017
Respiratory Testing and Reimbursement: Charles Mathews, Vice President on the dynamics of respiratory testing, coding options, and payer coverage, and how payment will evolve in the future.
September 14, 2017
Diagnostics World News – ‘Defining Good: Charles Mathews On Setting Our Own Evidence Standards In Diagnostics’
September 6, 2017
On site at the Next Generation Dx Summit, Vice President, Charles Mathews tells Diagnostics World editor Allison Proffitt that the diagnostics industry needs to create its own evidence standard and to outline clearly what levels of evidence should be required.
August 21, 2017
GenomeWeb: ‘Insurers Turn to Automated Prior Authorization Programs to Rein in Genetic Testing Use’
May 31, 2017
Life sciences consultancy, Boston Healthcare Associates and market research institute Data Information Intelligence (dii) GmbH haveannounced a partnership aimed at commercializing life sciences data and analytics for biopharmaceutical, medical device and diagnostic companies.
May 24, 2017
Slone Partners: Leadership Series Featuring Charles Mathews, Vice President at Boston Healthcare.
April 22, 2017
New research on rheumatoid arthritis(RA) by Boston Healthcare shows that the value of biologic treatments is greater than initial assessments.
16 February, 2017
iSpecimen Founder & CEO to Present on Emerging Technology Keynote Panel at Molecular Med Tri-Con.